Bcworldpharm Co (XKRX:200780) Beneish M-Score: -2.64 (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:200780 Bcworldpharm Co Ltd XKRX:200780
66 GF Score
Price ₩3,040.00
GF Value ₩5,477.85
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bcworldpharm Co Beneish M-Score?

Bcworldpharm Co XKRX:200780 +1.00% 66 Beneish M-Score is -2.64 as of Sep. 13, 2026. GuruFocus rates XKRX:200780 with a GF Score™ of 66/100 and a GF Value™ of ₩5,477.85 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, Bcworldpharm Co ranks better than 62.17% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.64 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Bcworldpharm Co's Beneish M-Score or its related term are showing as below:

XKRX:200780' s Beneish M-Score Range Over the Past 10 Years
Min: -3.01   Med: -2.64   Max: -2.06
Current: -2.64

During the past 13 years, the highest Beneish M-Score of Bcworldpharm Co was -2.06. The lowest was -3.01. And the median was -2.64.


Bcworldpharm Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Bcworldpharm Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bcworldpharm Co Beneish M-Score Chart

Bcworldpharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.59 -2.84 -2.57 -2.53 -2.89

Bcworldpharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.76 -2.62 -2.89 -2.62 -2.64

XKRX:200780 vs LLY, JNJ, ABBV: Beneish M-Score Comparison

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Beneish M-Score falls into.


XKRX:200780
66GF Score
Bcworldpharm Co Ltd XKRX:200780
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bcworldpharm Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Bcworldpharm Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9764+0.528 * 1.0655+0.404 * 0.8369+0.892 * 1.0665+0.115 * 0.936
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9102+4.679 * -0.043995-0.327 * 0.9094
=-2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was ₩19,490 Mil.
Revenue was 20958.384 + 19834.736 + 20283.721 + 19251.266 = ₩80,328 Mil.
Gross Profit was 7335.595 + 8000.621 + 8063.893 + 7122.428 = ₩30,523 Mil.
Total Current Assets was ₩48,139 Mil.
Total Assets was ₩173,613 Mil.
Property, Plant and Equipment(Net PPE) was ₩116,515 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩8,206 Mil.
Selling, General, & Admin. Expense(SGA) was ₩6,531 Mil.
Total Current Liabilities was ₩91,553 Mil.
Long-Term Debt & Capital Lease Obligation was ₩0 Mil.
Net Income was -1134.05 + 332.937 + -983.607 + -1112.666 = ₩-2,897 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was 3732.548 + -1551.112 + 1130.047 + 1429.151 = ₩4,741 Mil.
Total Receivables was ₩18,715 Mil.
Revenue was 20442.441 + 15822.548 + 21527.373 + 17523.865 = ₩75,316 Mil.
Gross Profit was 8741.123 + 6658.413 + 8714.195 + 6379.731 = ₩30,493 Mil.
Total Current Assets was ₩45,290 Mil.
Total Assets was ₩174,776 Mil.
Property, Plant and Equipment(Net PPE) was ₩118,710 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩7,791 Mil.
Selling, General, & Admin. Expense(SGA) was ₩6,728 Mil.
Total Current Liabilities was ₩91,328 Mil.
Long-Term Debt & Capital Lease Obligation was ₩10,021 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(19489.732 / 80328.107) / (18714.5 / 75316.227)
=0.242627 / 0.248479
=0.9764

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(30493.462 / 75316.227) / (30522.537 / 80328.107)
=0.404872 / 0.379973
=1.0655

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (48138.896 + 116515.056) / 173613.027) / (1 - (45289.604 + 118709.509) / 174775.999)
=0.051604 / 0.061661
=0.8369

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=80328.107 / 75316.227
=1.0665

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7790.735 / (7790.735 + 118709.509)) / (8206.235 / (8206.235 + 116515.056))
=0.061587 / 0.065797
=0.936

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(6531.253 / 80328.107) / (6728.232 / 75316.227)
=0.081307 / 0.089333
=0.9102

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 91552.601) / 173613.027) / ((10021.154 + 91328.001) / 174775.999)
=0.527337 / 0.57988
=0.9094

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-2897.386 - 0 - 4740.634) / 173613.027
=-0.043995

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Bcworldpharm Co has a M-score of -2.64 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.64 mean?
Bcworldpharm Co (XKRX:200780) has a Beneish M-Score of -2.64 as of Sep. 13, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bcworldpharm Co and its competitors. According to the industry distribution chart, Bcworldpharm Co ranks #348 out of 920 companies in the Drug Manufacturers industry, placing it in the top 37.8%.
Is Bcworldpharm Co's Beneish M-Score too high?
Bcworldpharm Co's current Beneish M-Score is -2.64. Based on the distribution chart, Bcworldpharm Co ranks #348 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Beneish M-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Bcworldpharm Co ranks #348 out of 920 companies for Beneish M-Score. This puts Bcworldpharm Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bcworldpharm Co and its competitors. Bcworldpharm Co's current Beneish M-Score is -2.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Beneish M-Score is -2.64. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Beneish M-Score is -2.64 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?

Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued. The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85. GuruFocus considers Bcworldpharm Co to be Possible Value Trap.

Key valuation signals for XKRX:200780:

  • Beneish M-Score: -2.64
  • GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bcworldpharm Co Business Description

Address 872-23 Yeoju-nam-ro, Ganam-eup, Gyeonggi-do, Yeoju-si, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score

Get the complete analysis for XKRX:200780

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,040.00
Price
₩5,477.85
GF Value